Wednesday, May 21, 2025 | 04:21 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Covid-19 vaccine stock-taking: Does India have enough to expand the drive?

Zydus Cadila's yet to be launched DNA plasmid vaccine ZyCoV-D is expected to add to the vaccine supply

vaccine
Premium

SII is in a wait-and-watch mode before it steps on the gas to produce a large number of Covishield doses

Sohini Das Mumbai
India will begin to give a third shot to a section of its elderly population from January 10, besides opening up vaccination for children aged 15 and above. But do we have enough vaccine stockpiles in the country to support a seamless drive?

A back of the envelope calculation shows that India has roughly over 680 million doses of Covid-19 vaccines consisting primarily of Covishield doses. This includes the 179 million unused doses available with states as of December 26, and a stockpile of 500 million doses lying at Serum Institute of India’s (SII) Pune plant.

Vaccination for children aged 15 and

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in